Biotrin Control Parvovirus B19 IgM (2014-01-07) — recall 50641
Health Canada — Medical Devices · Canada · 2014-02-11 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Internal investigation confirmed that C of A of Biotrin Control Parvovirus B19 IGM is reporting an incorrect negative control range for the Liaison XL application when used in combination with Biotrin Parvovirus B19 IGM kit.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.